News & Updates

Some parameters that are usually assessed intraoperatively during stage 1 sacral neuromodulation appear to be of little use in predicting acute and long-term outcomes in urgency urinary incontinence, reveals a study.

An integrated analysis of the pivotal phase IIb/III ALLEGRO and phase III ALLEGRO-LT studies demonstrated the long-term efficacy of the oral JAK3/TEC family kinase inhibitor ritlecitinib for alopecia areata (AA).

Risperidone use among patients with schizophrenia appears to confer some protection against the risk of kidney function decline, as reported in a study.

The duration of acute kidney injury (AKI) was associated with the risks of chronic kidney disease (CKD) but not overall cardiovascular disease (CVD*), a population-based Danish cohort study suggests.

Maintenance therapy with niraparib appears to increase progression-free survival (PFS) in patients with advanced ovarian cancer, irrespective of postoperative residual disease or biomarker status, according to data from the phase III PRIME study.

For postmenopausal women with a history of gestational diabetes, delivering high birth weight infants or hypertensive disorders of pregnancy poses a heightened risk of developing type 2 diabetes (T2D) in the future, according to a study.